These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8048910)

  • 1. Bluetongue virus infection in sheep: haematological changes and detection by polymerase chain reaction.
    McColl KA; Gould AR
    Aust Vet J; 1994 Apr; 71(4):97-101. PubMed ID: 8048910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bluetongue virus-induced interferon in cattle.
    MacLachlan NJ; Thompson J
    Am J Vet Res; 1985 Jun; 46(6):1238-41. PubMed ID: 2411172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of Spanish Ibex (Capra pyrenaica) against Bluetongue virus serotypes 1 and 8 in a subclinical experimental infection.
    Lorca-Oró C; Pujols J; García-Bocanegra I; Mentaberre G; Granados JE; Solanes D; Fandos P; Galindo I; Domingo M; Lavín S; López-Olvera JR
    PLoS One; 2012; 7(5):e36380. PubMed ID: 22666321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
    Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
    Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contamination in bluetongue virus challenge experiments.
    Eschbaumer M; Wäckerlin R; Savini G; Zientara S; Sailleau C; Bréard E; Beer M; Hoffmann B
    Vaccine; 2011 Jun; 29(26):4299-301. PubMed ID: 21557978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the minimum protective dose for bluetongue virus serotype 2 and 8 vaccines in sheep.
    Modumo J; Venter EH
    J S Afr Vet Assoc; 2012 Aug; 83(1):17. PubMed ID: 23327131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of bluetongue virus in the blood of inoculated calves: comparison of virus isolation, PCR assay, and in vitro feeding of Culicoides variipennis.
    MacLachlan NJ; Nunamaker RA; Katz JB; Sawyer MM; Akita GY; Osburn BI; Tabachnick WJ
    Arch Virol; 1994; 136(1-2):1-8. PubMed ID: 8002778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic response of sheep to inactivated and virulent bluetongue virus.
    Stott JL; Barber TL; Osburn BI
    Am J Vet Res; 1985 May; 46(5):1043-9. PubMed ID: 2988376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Full-Genome Sequencing of Four Bluetongue Virus Serotype 11 Viruses.
    Vandenbussche F; Sailleau C; Rosseel T; Desprat A; Viarouge C; Richardson J; Eschbaumer M; Hoffmann B; De Clercq K; Bréard E; Zientara S
    Transbound Emerg Dis; 2015 Oct; 62(5):565-71. PubMed ID: 24750582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17.
    Speiser KL; Schumaker BA; Cook WE; Cornish TE; Cammack KM; Miller MM
    J Am Vet Med Assoc; 2016 May; 248(9):1043-9. PubMed ID: 27074613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA.
    Feenstra F; Maris-Veldhuis M; Daus FJ; Tacken MG; Moormann RJ; van Gennip RG; van Rijn PA
    Vaccine; 2014 Dec; 32(52):7108-14. PubMed ID: 25454873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T lymphocyte subset alterations following bluetongue virus infection in sheep and cattle.
    Ellis JA; Luedke AJ; Davis WC; Wechsler SJ; Mecham JO; Pratt DL; Elliott JD
    Vet Immunol Immunopathol; 1990 Jan; 24(1):49-67. PubMed ID: 2156375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bluetongue virus RNA detection by RT-qPCR in blood samples of sheep vaccinated with a commercially available inactivated BTV-8 vaccine.
    Steinrigl A; Revilla-Fernández S; Eichinger M; Koefer J; Winter P
    Vaccine; 2010 Aug; 28(34):5573-81. PubMed ID: 20600511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pathology of Australian bluetongue virus serotype 16 infection in merino sheep.
    Flanagan M; Johnson SJ; Hoffmann D; Polkinghorne IG; Reid DJ; Shepherd MA
    Aust Vet J; 1993 Mar; 70(3):101-4. PubMed ID: 8386503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of clinical courses, gross lesions, acute phase response and coagulation disorders in sheep inoculated with bluetongue virus serotype 1 and 8.
    Sánchez-Cordón PJ; Pleguezuelos FJ; Pérez de Diego AC; Gómez-Villamandos JC; Sánchez-Vizcaíno JM; Cerón JJ; Tecles F; Garfia B; Pedrera M
    Vet Microbiol; 2013 Sep; 166(1-2):184-94. PubMed ID: 23849094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of genome segments 2, 7 and 10 of bluetongue viruses serotype 2 for differentiation between field isolates and the vaccine strain.
    Bréard E; Sailleau C; Coupier H; Mure-Ravaud K; Hammoumi S; Gicquel B; Hamblin C; Dubourget P; Zientara S
    Vet Res; 2003; 34(6):777-89. PubMed ID: 14746772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bluetongue virus serotype 27: Experimental infection of goats, sheep and cattle with three BTV-27 variants reveal atypical characteristics and likely direct contact transmission BTV-27 between goats.
    Bréard E; Schulz C; Sailleau C; Bernelin-Cottet C; Viarouge C; Vitour D; Guillaume B; Caignard G; Gorlier A; Attoui H; Gallois M; Hoffmann B; Zientara S; Beer M
    Transbound Emerg Dis; 2018 Apr; 65(2):e251-e263. PubMed ID: 29243405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular differentiation between NS1 gene of a field strain Bluetongue virus serotype 2 (BTV-2) and NS1 gene of an attenuated BTV-2 vaccine.
    Agüero M; Arias M; Romero LJ; Zamora MJ; Sánchez-Vizcaíno JM
    Vet Microbiol; 2002 May; 86(4):337-41. PubMed ID: 11955783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
    Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
    Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.